Humana (HUM) Asset Writedowns and Impairment (2022 - 2026)

Humana (HUM) has reported Asset Writedowns and Impairment for 5 consecutive years, with $23.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Asset Writedowns and Impairment fell 28.12% year-over-year to $23.0 million; the TTM figure through Jun 2026 stood at $112.0 million (down 53.53% YoY), while the FY2025 annual figure was $128.0 million, down 45.99% from the prior year.
• Asset Writedowns and Impairment advanced to $23.0 million in Q2 2026 per HUM's latest filing, from $2.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $200.0 million in Q4 2024 and bottomed at -$9.0 million in Q3 2025.
• Historically, Asset Writedowns and Impairment has averaged $58.3 million across 5 years, with a median of $31.5 million in 2023.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment jumped 675.0% — and 2026, when it sank 77.78%.
• Humana's Asset Writedowns and Impairment stood at $104.0 million in 2022, then jumped by 68.27% to $175.0 million in 2023, then increased by 14.29% to $200.0 million in 2024, then tumbled by 52.0% to $96.0 million in 2025, then plunged by 76.04% to $23.0 million in 2026.
• Business Quant data shows HUM's Asset Writedowns and Impairment at $23.0 million in Q2 2026, $2.0 million in Q1 2026, and $96.0 million in Q4 2025.